Posted inBiotechnology
Immunology biotech Nilo launches with $101M and mission to harness neural circuits
Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to…
Posted inBiotechnology
Sanofi’s $110M radioligand therapy hits response rate goal in phase 2 tumor trial
Sanofi’s $110 million bet on a radioligand seems to be paying off after the neuroendocrine tumor treatment hit the key endpoints…
Posted inMedical Technology
Alpenglow teams up with Virdx to boost prostate cancer diagnosis with Nvidia, AI power
Alpenglow Biosciences has penned a new, multiyear strategic agreement with Virdx to create the next generation of artificial-intelligence-powered tools aimed…
Posted inBiotechnology
After high-profile FDA exit, Peter Marks lands at Eli Lilly
Peter Marks, M.D., Ph.D., the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli…
Posted inBiotechnology
US government earmarks up to $48M for development of Kernal’s mRNA CAR-T
The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s…
Posted inBiotechnology
Langer family RNA biotech Soufflé rises with $200M and Big Pharma partners
A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned…
Posted inBiotechnology
Learn strategies to address PFAS challenges facing the medical device industry.
In recent years, the presence of per- and poly-fluoroalkyl substances (PFAS), commonly known as "forever chemicals," in medical devices has…
Posted inMedical Technology
Jupiter Endovascular exceeds $40M series B fundraising target for its TFX platform
Jupiter Endovascular, which is a startup spun out of Neptune Medical a year ago, raised more than its target of…
Posted inMedical Technology
Olympus, W.L. Gore link on global distribution deal for endoscopic placement tool
Olympus has inked a collaboration deal with U.S.-based W.L. Gore, giving the Japanese medtech giant rights to be the international…
Posted inMedical Technology
Encora names Nadim Yared CEO as co-founder, previous chief Daniel Carballo takes VP role
Encora Therapuetics, maker of a wearable device that targets essential tremors in patients, named Nadim Yared as chairman and CEO…